Use of an mTOR inhibitor in treatment of uterine leiomyoma
US7528145B2 · kind B2 · utility
0Cited by
43References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 21, 2005 |
| Grant date | May 5, 2009 |
| Priority date | — |
| Expiry date | Oct 21, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides for the use of an mTOR inhibitor in the treatment or inhibition of fibroids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.